Development of a Digital Rehab Program With Gamification
Development and Clinical Validation of a Novel Digital Rehabilitative Exercise Program With Gamification and Vision Technology
1 other identifier
interventional
21
1 country
1
Brief Summary
Total knee arthroplasty is commonly followed by a period of postoperative rehabilitation to restore knee movement, lower-limb strength, and physical function. This randomized study evaluated KIMIA Recover, a wearable sensor-supported home rehabilitation system, in patients undergoing first-time unilateral total knee arthroplasty. Participants were randomly allocated to KIMIA Recover-supported rehabilitation or conventional postoperative rehabilitation and followed for 12 weeks after surgery. KIMIA Recover comprises a wearable knee motion sensor, a patient mobile application providing guided rehabilitation exercises and feedback, and a clinician dashboard that enables review of rehabilitation progress. Outcomes included knee range of motion, 30-second sit-to-stand performance, health-related quality of life, healthcare resource use and costs, quadriceps strength, straight-leg-raise ability, walking-device use, Oxford Knee Score, and postoperative complications. The randomized phase was originally designed to recruit a larger cohort but enrolled 21 participants. Because recruitment and follow-up were limited, the completed study is being reported as a pilot and feasibility evaluation, with clinical between-group comparisons considered exploratory. This ClinicalTrials.gov record is being registered retrospectively after completion of participant recruitment and follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedFirst Submitted
Initial submission to the registry
September 22, 2026
CompletedFirst Posted
Study publicly available on registry
September 29, 2026
CompletedSeptember 30, 2026
September 1, 2026
9 months
September 22, 2026
September 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient retention
Patient retention and drop out rate
0,4,12 weeks
Postoperative Complications
Number and proportion of participants experiencing postoperative complications or adverse effects following total knee arthroplasty during the study follow-up period.
4 weeks (±2 weeks) and 12 weeks (±2 weeks) after total knee arthroplasty
Secondary Outcomes (3)
Change in Quadriceps Muscle Strength
Baseline, 4 weeks (±2 weeks), and 12 weeks (±2 weeks) after total knee arthroplasty
Change in Knee Range of Motion
Baseline, 4 weeks (±2 weeks), and 12 weeks (±2 weeks) after total knee arthroplasty
Change in Oxford Knee Score
Baseline and 12 weeks after total knee arthroplasty
Study Arms (2)
KIMIA Recover-Supported Rehabilitation
EXPERIMENTALParticipants received usual perioperative and postoperative rehabilitation together with KIMIA Recover, comprising a wearable knee motion sensor, mobile rehabilitation application, and clinician dashboard. Participants were trained to use the sensor and application and were instructed to use the system during inpatient rehabilitation and for up to 12 weeks following total knee arthroplasty.
Standard-of-Care Rehabilitation
ACTIVE COMPARATORParticipants received usual perioperative rehabilitation and conventional home-based postoperative rehabilitation without technology-supported monitoring. They were provided with prescribed rehabilitation exercises and could attend outpatient physiotherapy according to clinical need.
Interventions
KIMIA Recover is a wearable sensor-supported postoperative rehabilitation system comprising a knee motion sensor, patient mobile application, and clinician dashboard. The application provides rehabilitation education, guided exercises, visual and audio cues, feedback, reminders, and progress tracking. The clinician dashboard enables healthcare professionals to review rehabilitation progress and exercise participation. Participants were instructed to wear the sensor for 12-16 hours per day during the inpatient period and for 8-12 hours per day during active and exercise periods after discharge, for up to 12 weeks
Participants performed prescribed home rehabilitation exercises without wearable or application-based monitoring. Outpatient physiotherapy was provided according to clinical need, including assessment of recovery, exercise instruction, feedback, and progression of exercises.
Eligibility Criteria
You may qualify if:
- First-time unilateral total knee replacement
- Eligible for the institutional Enhanced Recovery After Surgery programme
- Age 21 to 90 years
- Able to provide written informed consent
- Proficient in smartphone use
- Adequate cognitive function to understand and comply with study instructions
- No uncontrolled medical condition expected to adversely affect postoperative outcomes
- Willing to comply with study procedures and follow-up
You may not qualify if:
- Previous total knee replacement of the contralateral knee or scheduled revision total knee replacement
- Limb disorder that may interfere with measurement of knee movement
- Planned discharge to a destination other than home
- Difficulty following, applying, or using the KIMIA Recover system
- Previous lower-limb surgery other than total knee replacement
- Dependence in activities of daily living requiring caregiver assistance
- Scheduled partial or unicompartmental knee replacement
- Significant cognitive impairment or dementia that may interfere with study participation
- Unable to establish or maintain reliable communication with the study team
- Poorly controlled medical conditions, including uncontrolled diabetes, hypertension, metabolic disease, or cardiovascular disease
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tan Tock Seng Hospitallead
- Kinexcs Private Limitedcollaborator
Study Sites (1)
Tan Tock Seng Hospital
Singapore, Singapore, 308433, Singapore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participants and investigators were not blinded because the intervention required participants to use a wearable sensor and mobile rehabilitation application.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2026
First Posted
September 29, 2026
Study Start
November 24, 2024
Primary Completion
August 19, 2025
Study Completion
August 30, 2025
Last Updated
September 30, 2026
Record last verified: 2026-09